Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Valerie L. Ruberto"'
Publikováno v:
Pharmaceuticals, Vol 13, Iss 6, p 116 (2020)
Over a third of patients with major depressive disorder (MDD) do not have an adequate response to first-line antidepressant treatments, i.e., they have treatment-resistant depression (TRD). These patients tend to have a more severe course of illness
Externí odkaz:
https://doaj.org/article/6ba6894a7d2943028dccf958ce7c40f3
Publikováno v:
Drug Design, Development and Therapy
Major depressive disorder (MDD) is widely prevalent and one of the leading causes of disability. Treatment outcomes remain suboptimal with 1 in 3 patients with MDD responding inadequately to commonly used antidepressants. Pimavanserin, an atypical an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aafb308f44d7d74fdc731e2e0d8a8d87
http://europepmc.org/articles/PMC7812044
http://europepmc.org/articles/PMC7812044
Autor:
Maya Kuperberg, Melvin G. McInnis, Richard C. Shelton, Edward S. Friedman, Mauricio Tohen, Louisa G. Sylvia, Valerie L. Ruberto, Ole Köhler-Forsberg, Charles L. Bowden, Terence A. Ketter, Andrew A. Nierenberg, Michael J. Ostacher, Susan L. McElroy, Michael E. Thase, Lindsay Overhage, Dan V. Iosifescu, James H. Kocsis, Vicki Fung, Alec P. Shannon, Joseph R. Calabrese, Thilo Deckersbach
Publikováno v:
Journal of Affective Disorders. 273:131-137
Background Bipolar disorder is a heritable disorder, and we aimed to assess the impact of family history of mental disorders in first-degree relatives on the severity and course of bipolar disorder. Methods The Bipolar CHOICE (lithium versus quetiapi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3372483672adcc3794bbb469216e8de4
https://doi.org/10.1016/j.jad.2020.03.157
https://doi.org/10.1016/j.jad.2020.03.157
Publikováno v:
Pharmaceuticals, Vol 13, Iss 116, p 116 (2020)
Pharmaceuticals
Pharmaceuticals
Over a third of patients with major depressive disorder (MDD) do not have an adequate response to first-line antidepressant treatments, i.e., they have treatment-resistant depression (TRD). These patients tend to have a more severe course of illness
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a931fcb1b9a2d37ad5f2a341ebb52f8
https://www.mdpi.com/1424-8247/13/6/116
https://www.mdpi.com/1424-8247/13/6/116